NRF2-Mediated Proteostatic Convergence: Shared Oxidative Stress Response Failure Links PD (SNCA Aggregation) and AD (Abeta/Tau Accumulation)
🧪 Overview
Convergence hypothesis: NRF2 (NFE2L2) is the central transcriptional regulator whose failure explains parallel proteostatic collapse in both PD and AD, making it a high-priority cross-disease target.
PD-specific mechanism: NRF2 regulates ARE-containing genes (HMOX1, NQO1, GCLC, GSTM1) that detoxify reactive oxygen species generated by mitochondrial dysfunction and neuromelanin iron accumulation. In PD, KEAP1 releases NRF2 in early disease to compensate, but chronic oxidative stress (elevated 4-HNE, 8-OHdG in substantia nigra) eventually overwhelms this response, leading to NRF2 nuclear translocation failure. The resulting proteasome (PSMB5, PSMD4) and autophagy (LAMP2A, GABARAP) failure accelerates α-synuclein aggregation.
AD-specific mechanism: NRF2 activity declines with age in AD brain. Amyloid-beta 42 (via RAGE/NF-κB) and phosphorylated tau (via GSK3B) both suppress NRF2 transcription and promote KEAP1 sequestration. This reduces expression of HMOX1, NQO1, and proteasome subunits PSMB1/PSMB5, impairing clearance of both Abeta and tau aggregates.
🧬 Mechanism
Curated pathway from expert analysis
flowchart TD
A["Oxidative Stress<br/>PD SNCA and AD Abeta Tau Burden"]
B["KEAP1 NRF2 Switch<br/>NFE2L2 Stabilization"]
C["ARE Gene Program<br/>HMOX1 NQO1 GCLC GSTM1"]
D["SQSTM1 Autophagy Coupling<br/>Proteostatic Clearance"]
E["Chronic Stress NRF2 Failure<br/>Antioxidant Exhaustion"]
F["Proteasome and Autophagy Collapse<br/>Aggregate Accumulation"]
G["PD AD Shared Vulnerability<br/>Proteostatic Convergence"]
A --> B
B --> C
C --> D
A --> E
E --> F
D -.->|"when insufficient"| F
F --> G
style B fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
style G fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a⚖️ Evidence
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — NFE2L2
No curated PDB or AlphaFold mapping for NFE2L2 yet. Search RCSB →
💉 Clinical Trials (1)Relevance: 80%
Active
Completed
Total Enrolled
Highest Phase
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for NFE2L2,KEAP1,HMOX1,SQSTM1,PSMB5.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
🏆 Tournament
🏆 Arenas / Elo
📊 Market Indicators
💾 Resource Usage
No resource usage or linked notebooks recorded for this hypothesis yet.
🔮 Predictions
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| KEAP1/NRF2/CUL3 ratio in post-mortem PD putamen and AD hippocampus shows KEAP1 elevated >2-fold and NRF2 reduced >50% compared to age-matched controls. | — | — no observation — | open | 0.78 |
| NRF2 activator (dimethyl fumarate 30mg/kg/day PO 8 weeks) will reduce both soluble α-synuclein (Ser129-P) and total tau (Tau5) in A53T SNCA transgenic mice. | — | — no observation — | open | 0.75 |
▸Metadatasource: v1_phase_c_backfill · origin_type: comparative_synthesis
| source | v1_phase_c_backfill |
| origin_type | comparative_synthesis |
| _schema_version | 1 |